IL144460A0 - Inhibitors for use in hemostasis and immune function - Google Patents

Inhibitors for use in hemostasis and immune function

Info

Publication number
IL144460A0
IL144460A0 IL14446000A IL14446000A IL144460A0 IL 144460 A0 IL144460 A0 IL 144460A0 IL 14446000 A IL14446000 A IL 14446000A IL 14446000 A IL14446000 A IL 14446000A IL 144460 A0 IL144460 A0 IL 144460A0
Authority
IL
Israel
Prior art keywords
hemostasis
inhibitors
immune function
related protein
complement related
Prior art date
Application number
IL14446000A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL144460A0 publication Critical patent/IL144460A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14446000A 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function IL144460A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25360499A 1999-02-19 1999-02-19
US44479499A 1999-11-22 1999-11-22
PCT/US2000/004161 WO2000048625A2 (en) 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function

Publications (1)

Publication Number Publication Date
IL144460A0 true IL144460A0 (en) 2002-05-23

Family

ID=26943406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14446000A IL144460A0 (en) 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function

Country Status (20)

Country Link
US (1) US6448221B1 (xx)
EP (2) EP1382345A3 (xx)
JP (1) JP2002537270A (xx)
KR (1) KR20010102130A (xx)
CN (1) CN1341027A (xx)
AT (1) ATE245439T1 (xx)
AU (1) AU772103B2 (xx)
BR (1) BR0008298A (xx)
CA (1) CA2361273A1 (xx)
CZ (1) CZ20012916A3 (xx)
DE (1) DE60004015T2 (xx)
DK (1) DK1154785T3 (xx)
ES (1) ES2202061T3 (xx)
HK (1) HK1039892A1 (xx)
HU (1) HUP0105284A3 (xx)
IL (1) IL144460A0 (xx)
NO (1) NO20014012L (xx)
PL (1) PL349924A1 (xx)
PT (1) PT1154785E (xx)
WO (1) WO2000048625A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
MXPA03002871A (es) 2000-09-29 2004-12-06 Johnson & Johnson Dispositivos medicos recubiertos.
US20030220253A1 (en) * 2002-03-08 2003-11-27 Lasser Gerald W. Inhibitors for use in hemostasis
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
US9471978B2 (en) 2004-10-04 2016-10-18 Banner Health Methodologies linking patterns from multi-modality datasets
US7964557B2 (en) * 2005-03-28 2011-06-21 University Of Louisville Research Foundation, Inc. Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30
WO2007014798A2 (en) * 2005-07-29 2007-02-08 Laboratoires Serono S.A. Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases
WO2008075589A1 (ja) 2006-12-21 2008-06-26 Chisso Corporation 血小板凝集惹起物質
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
WO2023215294A1 (en) * 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Complement pathway inhibition for wound healing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
CA2295474A1 (en) 1997-07-08 1999-01-21 Human Genome Sciences, Inc. 123 human secreted proteins
IL134011A0 (en) * 1997-07-18 2001-04-30 Zymogenetics Inc Adipocyte-specific protein homologs
DE69837761T2 (de) 1997-08-01 2008-01-17 Serono Genetics Institute S.A. 5' ests für sekretierte proteine aus gehirngeweben
ATE324443T1 (de) 1997-08-26 2006-05-15 Zymogenetics Inc Für adipozyten spezifische protein homologe
DE69837678T2 (de) 1997-10-29 2007-12-27 Otsuka Pharmaceutical Co., Ltd. Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
NZ527898A (en) 1997-12-03 2005-01-28 Genentech Inc PRO347 polypeptides and nucleic acids encoding proteins with homology to cysteine-rich secretory protein-3
EP1042470A2 (en) 1997-12-30 2000-10-11 Chiron Corporation Bone marrow secreted proteins and polynucleotides
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
JP2002512798A (ja) 1998-04-29 2002-05-08 ジェネシス リサーチ アンド デベロップメント コーポレイション リミテッド 皮膚細胞から単離したポリヌクレオチドおよびその使用方法
WO1999059618A1 (en) 1998-05-21 1999-11-25 Smithkline Beecham Corporation Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)

Also Published As

Publication number Publication date
NO20014012L (no) 2001-10-02
HUP0105284A2 (hu) 2002-05-29
US6448221B1 (en) 2002-09-10
WO2000048625A2 (en) 2000-08-24
DE60004015D1 (de) 2003-08-28
HUP0105284A3 (en) 2003-12-29
HK1039892A1 (zh) 2002-05-17
ATE245439T1 (de) 2003-08-15
CN1341027A (zh) 2002-03-20
EP1154785B1 (en) 2003-07-23
AU772103B2 (en) 2004-04-08
AU2883200A (en) 2000-09-04
EP1382345A2 (en) 2004-01-21
JP2002537270A (ja) 2002-11-05
BR0008298A (pt) 2002-02-19
EP1154785A2 (en) 2001-11-21
DK1154785T3 (da) 2003-11-17
NO20014012D0 (no) 2001-08-17
ES2202061T3 (es) 2004-04-01
PT1154785E (pt) 2003-12-31
PL349924A1 (en) 2002-10-21
CZ20012916A3 (cs) 2002-05-15
DE60004015T2 (de) 2004-04-15
WO2000048625A3 (en) 2000-12-28
KR20010102130A (ko) 2001-11-15
EP1382345A3 (en) 2004-01-28
CA2361273A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
IL144460A0 (en) Inhibitors for use in hemostasis and immune function
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
WO1994016073A3 (en) Methods and reagents for inhibiting furin endoprotease
EP1918298A3 (en) Peptide
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
CA2340320A1 (en) Use of an angiogenic factor for the treatment of microascular angiopathies
EP0651655A4 (en) REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
GB9930768D0 (en) Composition
PL354961A1 (en) Prevention and treatment of diseases associated with blood coagulation
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
IL130500A0 (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE439142T1 (de) Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung
DE50207168D1 (de) Kombinationspräparat zur Therapie von immunologischen Erkrankungen
GEP19991605B (en) Inhibitor, Its Obtaining and Use
LT2002109A (en) Oinment for treatment of wounds and burnings